CR10003A - Prodrogas de sulfonato de sulfamoilo - Google Patents
Prodrogas de sulfonato de sulfamoiloInfo
- Publication number
- CR10003A CR10003A CR10003A CR10003A CR10003A CR 10003 A CR10003 A CR 10003A CR 10003 A CR10003 A CR 10003A CR 10003 A CR10003 A CR 10003A CR 10003 A CR10003 A CR 10003A
- Authority
- CR
- Costa Rica
- Prior art keywords
- sulfamoil
- production
- sulfonate products
- sulfonate
- products
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Esta invención se relaciona con prodrogas de sulfonato de sulfamoilo de fórmula general I, con un proceso para su producción, con composiciones farmacéuticas que contienen estos compuestos, y con su uso para la producción de agentes farmacéuticos disponibles por vía oral. Los compuestos de acuerdo a la invención se unen a anhidrasas carbónicas e inhiben a estas enzimas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005057408A DE102005057408A1 (de) | 2005-11-30 | 2005-11-30 | Sulfamoylsulfonat-Prodrugs |
Publications (1)
Publication Number | Publication Date |
---|---|
CR10003A true CR10003A (es) | 2008-08-21 |
Family
ID=37983623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR10003A CR10003A (es) | 2005-11-30 | 2008-05-21 | Prodrogas de sulfonato de sulfamoilo |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1957513A2 (es) |
JP (1) | JP2009517424A (es) |
KR (1) | KR20080072956A (es) |
CN (1) | CN101316858A (es) |
AU (1) | AU2006319380A1 (es) |
BR (1) | BRPI0619253A2 (es) |
CA (1) | CA2632272A1 (es) |
CR (1) | CR10003A (es) |
DE (1) | DE102005057408A1 (es) |
EA (1) | EA200801306A1 (es) |
EC (1) | ECSP088489A (es) |
IL (1) | IL191570A0 (es) |
NO (1) | NO20082915L (es) |
WO (1) | WO2007062874A2 (es) |
ZA (1) | ZA200805659B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG174483A1 (en) * | 2009-03-24 | 2011-10-28 | Univ Singapore | Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd) |
CN101987101A (zh) * | 2009-08-05 | 2011-03-23 | 天津金耀集团有限公司 | 糖皮质激素芳香基氨磺酰基磺酸酯为活性成分的眼用抗炎组合物 |
CN101987104A (zh) * | 2009-08-05 | 2011-03-23 | 天津金耀集团有限公司 | 一种杂芳香基氨磺酰基羧酸酯碳酸酐酶抑制剂的眼用组合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10027887A1 (de) * | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
DE102004025985A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estriol- und Estetrol-Prodrugs |
DE102004025966A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estradiol-Prodrugs |
DE102004025986A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Steroid-Prodrugs mit androgener Wirkung |
-
2005
- 2005-11-30 DE DE102005057408A patent/DE102005057408A1/de not_active Ceased
-
2006
- 2006-11-27 BR BRPI0619253-0A patent/BRPI0619253A2/pt not_active Application Discontinuation
- 2006-11-27 WO PCT/EP2006/011726 patent/WO2007062874A2/de active Application Filing
- 2006-11-27 EA EA200801306A patent/EA200801306A1/xx unknown
- 2006-11-27 EP EP06829354A patent/EP1957513A2/de not_active Withdrawn
- 2006-11-27 JP JP2008542678A patent/JP2009517424A/ja active Pending
- 2006-11-27 CA CA002632272A patent/CA2632272A1/en not_active Abandoned
- 2006-11-27 CN CNA2006800449086A patent/CN101316858A/zh active Pending
- 2006-11-27 AU AU2006319380A patent/AU2006319380A1/en not_active Abandoned
- 2006-11-27 KR KR1020087015775A patent/KR20080072956A/ko not_active Application Discontinuation
-
2008
- 2008-05-20 IL IL191570A patent/IL191570A0/en unknown
- 2008-05-21 CR CR10003A patent/CR10003A/es not_active Application Discontinuation
- 2008-05-30 EC EC2008008489A patent/ECSP088489A/es unknown
- 2008-06-27 ZA ZA200805659A patent/ZA200805659B/xx unknown
- 2008-06-27 NO NO20082915A patent/NO20082915L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20082915L (no) | 2008-06-27 |
WO2007062874B1 (de) | 2007-09-27 |
ECSP088489A (es) | 2008-06-30 |
CN101316858A (zh) | 2008-12-03 |
BRPI0619253A2 (pt) | 2011-09-27 |
ZA200805659B (en) | 2009-10-28 |
WO2007062874A3 (de) | 2007-07-12 |
DE102005057408A1 (de) | 2007-05-31 |
AU2006319380A1 (en) | 2007-06-07 |
JP2009517424A (ja) | 2009-04-30 |
EP1957513A2 (de) | 2008-08-20 |
CA2632272A1 (en) | 2007-06-07 |
EA200801306A1 (ru) | 2008-10-30 |
IL191570A0 (en) | 2008-12-29 |
KR20080072956A (ko) | 2008-08-07 |
WO2007062874A2 (de) | 2007-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8693101A1 (es) | Compuestos de isoindol-imida y composiciones que los incluyen y mètodos para su uso | |
UY28747A1 (es) | Nuevo proceso para la sintesis y nueva forma cristalina de agomelatina y composiciones farmaceuticas que las contienen | |
UY29919A1 (es) | Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones | |
CR11618A (es) | Inhibidores macrocíclicos de serina proteasa | |
CU20090070A7 (es) | Nuevos derivados de sulfonamida como antagonistas de la bradiquinina | |
UY29530A1 (es) | Compuestos quimicos | |
CR10479A (es) | Modulares bencimidazolicos de vr1 | |
UY29479A1 (es) | Inhibidores de adn-pk | |
UY30025A1 (es) | Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
CR10696A (es) | Compuestos de n-metilaminometil isoindol, composiciones que las comprenden y metodos que utilizan los mismos | |
PA8796201A1 (es) | Agentes anti-infecciosos y su uso | |
ECSP067025A (es) | DERIVADOS DE TETRAAZABENZO [e] AZULENO Y SUS ANÁLOGOS | |
BRPI0607455A2 (pt) | composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica | |
AR058348A1 (es) | Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden | |
UY29607A1 (es) | Compuestos quimicos | |
CR9507A (es) | Sulfonamidas de diarisulfona y sus usos | |
CR10213A (es) | Moduladores de la proteína quinasa aurora | |
HN2008000088A (es) | Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen. | |
CR10557A (es) | Bencilaminas, un proceso para la produccion y su uso como agentes antiinflamatorios | |
BRPI0712889A8 (pt) | composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica. | |
ECSP099389A (es) | Nuevas formas cristalinas | |
UY30801A1 (es) | Compuestos calciliticos | |
GT200500382A (es) | Sulfonamido-macrociclos y sus sales como inhibidores de tie2, composicion farmaceutica que comprende estos compuestos, metodo de prepararlos y su uso | |
CR10003A (es) | Prodrogas de sulfonato de sulfamoilo | |
ECSP10010710A (es) | Nuevas carboxamidas heterociclicas para su uso como inhibidores de trombina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |